CEO Roundtable on Cancer’s Post

View organization page for CEO Roundtable on Cancer, graphic

1,041 followers

The Roundtable is very pleased to announce its new CEO, Sean Khozin. With years of experience in government and the private sector, Dr. Khozin will lead the Roundtable into the next stage of its evolution. Learn more: https://lnkd.in/eBDD-Mjx #cancerfight

  • No alternative text description for this image
Charles Hugh-Jones

CEO at Volastra Therapeutics

4mo

Congratulations Sean - fantastic to have your leadership and expertise leading the organization

James Dettore

Chairman & CEO at Brand Institute

4mo

Congratulations Dr. Khozin with your recent appointment as the new Chief Executive Officer of the CEO Roundtable on Cancer! Brand Institute and our regulatory subsidary Drug Safety Institute are proud to have you at the helm of this elite group of Oncology government, acadameia, and industry leaders all with the same misssion of improving cancer patients quality of life and ultimately finding a cure.

Jay Schnitzer

Senior Vice President, Corporate Chief Engineer, and Chief Medical Officer at MITRE

4mo

Congratulations Sean!

Congrats Sean Khozin !! Looking forward to working together!

Rebecca Miksad, MD, MMS, MPH

Mission-driven Physician-Scientist Leader and Digital Health Strategist | Oncology, Data Science & Clinical Trial Expert | I accelerate value creation and integration of healthcare technology & AI

4mo

Congrats! So glad you are leading this effort

Zhen Su, MD MBA

Physician Scientist, Entrepreneur and CEO at Marengo Therapeutics

4mo

Congratulations Sean Khozin! What a fantastic news for CEORT and PDS! Can not think of a better candidate for this role! Best wishes for a great new chapter.

Paul Howard, PhD

Senior Director Of Public Policy at Amicus Therapeutics

4mo

Congrats Sean Khozin! Terrific opportunity to drive cutting edge public-private partnerships to advance cancer treatment and prevention!

Dr.Praveen Kumar

Surgeon, C-Suite Clinician Executive

4mo

Hearty Congratulations Sean Khozin

See more comments

To view or add a comment, sign in

Explore topics